Overview

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Status:
Completed
Trial end date:
2020-08-06
Target enrollment:
Participant gender:
Summary
This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP-690,550.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Tofacitinib